No Data
No Data
Disc Medicine Reports Q3 2024 Results and Strategic Progress
Disc Medicine Is Maintained at Buy by HC Wainwright & Co.
Disc Medicine Analyst Ratings
Stifel Maintains Disc Medicine(IRON.US) With Buy Rating, Maintains Target Price $79
Morgan Stanley Maintains Disc Medicine(IRON.US) With Buy Rating, Maintains Target Price $85
Disc Medicine to Participate in Upcoming Investor Conferences
far008 : $Vast Renewables (VSTE.US)$ has no short shares. we should see an uptick
103822628 : Sorry , unusual volume ticks means wat?
Stock_Drift OP 103822628 : Look at the volume. It’s unusual